Want to join the conversation?
In 4Q16, $ALOG's medical imaging segment revenue fell 4% versus 4Q15. Ultrasound segment revenue was down 4% due to decline in legacy OEM probes. Security and detection revenue fell 45% in the quarter due to lower volume across all product lines.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.